Edward Faught
#165,466
Most Influential Person Now
Researcher
Edward Faught's AcademicInfluence.com Rankings
Edward Faughtcomputer-science Degrees
Computer Science
#9879
World Rank
#10362
Historical Rank
Computer Engineering
#139
World Rank
#141
Historical Rank
Data Science
#247
World Rank
#252
Historical Rank
Computational Linguistics
#2444
World Rank
#2468
Historical Rank
Download Badge
Computer Science
Edward Faught's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Edward Faught Influential?
(Suggest an Edit or Addition)Edward Faught's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. (1998) (1080)
- Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2004) (542)
- Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. (1998) (414)
- Patient‐Validated Content of Epilepsy‐Specific Quality‐of‐Life Measurement (1997) (351)
- Nonadherence to antiepileptic drugs and increased mortality (2008) (348)
- Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy (1997) (293)
- Improved health care resource utilization following video-eeg-confirmed diagnosis of nonepileptic psychogenic seizures (1998) (266)
- Placebo‐controlled study of the efficacy and safety of lamotrigine in patients with partial seizures (1993) (256)
- Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults (1999) (235)
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages (1996) (234)
- Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging (1996) (220)
- Functional imaging: II. Prediction of epilepsy surgery outcome (2008) (218)
- Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy (2004) (213)
- Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures (2001) (204)
- Cortical dysplasia in temporal lobe epilepsy: Magnetic resonance imaging correlations (1991) (199)
- Predictive value of magnetic resonance imaging in temporal lobe epilepsy surgery. (1993) (197)
- Impact of nonadherence to antiepileptic drugs on health care utilization and costs: Findings from the RANSOM study (2009) (196)
- Felbamate monotherapy for partial‐onset seizures (1993) (182)
- Seizures after primary intracerebral hemorrhage (1989) (181)
- Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New‐Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society (2004) (177)
- Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults (2002) (173)
- Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy (1999) (160)
- Cerebral complications of angiography for transient ischemia and stroke (1979) (157)
- Magnetic source imaging versus intracranial electroencephalogram in epilepsy surgery: A prospective study (2006) (153)
- Magnetic resonance imaging in childhood intractable partial epilepsies (1993) (153)
- Frequency of epilepsy in patients with psychogenic seizures monitored by video-EEG (2003) (149)
- Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. (1999) (147)
- Effect of epilepsy magnetic source imaging on intracranial electrode placement (2009) (146)
- Subjective versus objective memory change after temporal lobe epilepsy surgery. (1999) (141)
- Functional imaging: I. Relative predictive value of intracranial electroencephalography (2008) (140)
- Postmarketing Experience with Topiramate and Cognition (2001) (137)
- Incidence and prevalence of epilepsy among older US Medicare beneficiaries (2012) (137)
- Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy (1998) (134)
- Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T (1995) (129)
- Multimodality MRI in mesial temporal sclerosis: Relative sensitivity and specificity (1997) (127)
- Weight loss associated with vagus nerve stimulation (2002) (119)
- Topiramate increases cerebral GABA in healthy humans (1998) (118)
- Association of Combined MRI, Interictal EEG, and Ictal EEG Results with Outcome and Pathology After Temporal Lobectomy (1997) (118)
- Temporal lobe developmental malformations and epilepsy (1998) (116)
- Epilepsy surgery outcome (1997) (116)
- Physical Exercise, Stressful Life Experience, and Depression in Adults with Epilepsy (1994) (114)
- Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss? (2001) (111)
- Determining Reliable Cognitive Change after Epilepsy Surgery: Development of Reliable Change Indices and Standardized Regression‐based Change Norms for the WMS‐III and WAIS‐III (2002) (109)
- Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy (1997) (107)
- Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization (2012) (103)
- Individual Memory Change After Anterior Temporal Lobectomy: A Base Rate Analysis Using Regression‐Based Outcome Methodology (1998) (102)
- Felbamate: Consensus of current clinical experience (2006) (100)
- Rational polytherapy (2009) (97)
- Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy (2007) (97)
- Visual confrontation naming and hippocampal function: A neural network study using quantitative (1)H magnetic resonance spectroscopy. (2000) (89)
- The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy (2014) (89)
- Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy (2004) (88)
- Supplementary sensorimotor area epilepsy. Seizure localization, cortical propagation and subcortical activation pathways using ictal SPECT. (1997) (86)
- Adherence to antiepilepsy drug therapy (2012) (85)
- Low intensity vagal nerve stimulation lowers human thermal pain thresholds (2000) (85)
- Adding Lamotrigine to Valproate: Incidence of Rash and Other Adverse Effects (1999) (85)
- Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment (2006) (84)
- Occipital Lobe Developmental Malformations and Epilepsy: Clinical Spectrum, Treatment, and Outcome (1997) (84)
- A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events (2003) (83)
- Acute psychotic symptoms induced by topiramate (1999) (83)
- Quantitative MRI in temporal lobe epilepsy (1999) (83)
- Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy. (2012) (82)
- Detection of generalized tonic–clonic seizures using surface electromyographic monitoring (2017) (81)
- Cognitive Functioning in Community Dwelling Older Adults with Chronic Partial Epilepsy (2005) (80)
- Risk to verbal memory following anterior temporal lobectomy in patients with severe left-sided hippocampal sclerosis. (2002) (80)
- Significance of interictal temporal lobe delta activity for localization of the primary epileptogenic region (1999) (80)
- Safety and Tolerability of Gabapentin as Adjunctive Therapy in a Large, Multicenter Study (1999) (79)
- Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. (2003) (77)
- Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society (2004) (77)
- FRONTAL AND CENTRAL LOBE FOCAL DYSPLASIA: CLINICAL, EEG AND IMAGING FEATURES (1995) (77)
- Ambulatory EEG monitoring. (2017) (75)
- Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy (1999) (75)
- Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018) (75)
- Intravenous prostacyclin in acute nonhemorrhagic stroke: a placebo-controlled double-blind trial. (1987) (74)
- Congenital porencephaly: MR features and relationship to hippocampal sclerosis. (1998) (74)
- Racial disparities in the use of surgical treatment for intractable temporal lobe epilepsy (2005) (74)
- Appendix D: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2007) (74)
- Epidemiology and Drug Treatment of Epilepsy in Elderly People (1999) (73)
- Comparative Cognitive Effects of Carbamazepine and Gabapentin in Healthy Senior Adults (2001) (73)
- Temporal lobe developmental malformations and hippocampal sclerosis (1999) (73)
- Predictive value of 1H MRSI for outcome in temporal lobectomy (1999) (73)
- Wisconsin Card Sorting Performance in Patients With Temporal Lobe Epilepsy: Clinical and Neuroanatomical Correlates (2000) (72)
- Descriptive epidemiology of epilepsy in the U.S. population: A different approach (2015) (72)
- Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy (2000) (71)
- Long‐term safety and efficacy in patients with uncontrolled partial‐onset seizures treated with adjunctive lacosamide: Results from a phase III open‐label extension trial (2012) (71)
- What are the concerns of older adults living with epilepsy? (2005) (70)
- Volumetric MRI of the limbic system: anatomic determinants (1998) (67)
- Current Role of Electroencephalography in Cerebral Ischemia (1993) (66)
- Cognitive correlates of 1H MRSI–detected hippocampal abnormalities in temporal lobe epilepsy (1999) (65)
- Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy (2011) (64)
- Investigation of executive function change following anterior temporal lobectomy: selective normalization of verbal fluency. (2000) (64)
- Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. (1993) (62)
- Safety of Rapid Intravenous Loading of Valproate (2007) (59)
- Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society (1999) (59)
- MRI extrahippocampal volumes and visual memory: Correlations independent of MRI hippocampal volumes in temporal lobe epilepsy patients (1999) (59)
- The Safety of Rapid Valproic Acid Infusion (2000) (59)
- Self-report of cognitive abilities in temporal lobe epilepsy: cognitive, psychosocial, and emotional factors (2004) (58)
- Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018) (57)
- Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease (2013) (57)
- Relationships Among Hippocampal Volumetry, Proton Magnetic Resonance Spectroscopy, and Verbal Memory in Temporal Lobe Epilepsy (2001) (55)
- Rey Osterrieth complex figure test spatial and figural scoring: Relations to seizure focus and hippocampal pathology in patients with temporal lobe epilepsy (2008) (54)
- Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures (1995) (53)
- Postictal nose-rubbing in the diagnosis, lateralization, and localization of seizures (1999) (53)
- Long‐Term Experience with Topiramate as Adjunctive Therapy and as Monotherapy in Patients with Partial Onset Seizures: Retrospective Survey of Open‐Label Treatment (1997) (52)
- Ictal EEG wave forms from epidural electrodes predictive of seizure control after temporal lobectomy. (1992) (52)
- Qualitative MRI Segmentation in Mesial Temporal Sclerosis: Clinical Correlations (1996) (50)
- Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizures (2004) (48)
- Psychiatric and neurologic risk factors for incident cases of new‐onset epilepsy in older adults: Data from U.S. Medicare beneficiaries (2014) (48)
- Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy. Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society (2004) (47)
- Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures (2008) (43)
- Magnitude of the placebo effect in randomized trials of antiepileptic agents (2002) (43)
- Verbal memory outcome in patients with normal preoperative verbal memory and left mesial temporal sclerosis (2005) (42)
- Race/ethnicity, sex, and socioeconomic status as predictors of outcome after surgery for temporal lobe epilepsy. (2006) (41)
- Pharmacokinetic Considerations in Prescribing Antiepileptic Drugs (2001) (40)
- Adult myoclonic epilepsy: A distinct syndrome of idiopathic generalized epilepsy (2000) (40)
- Adult‐onset Neuronal Ceroid Lipofuscinosis (Kufs Disease) with Autosomal Dominant Inheritance in Alabama (1987) (39)
- Efficacy of gabapentin as adjunctive therapy in a large, multicenter study (2000) (39)
- Monotherapy in adults and elderly persons (2007) (38)
- Left vagus nerve stimulation suppresses experimentally induced pain (2001) (38)
- Topiramate in the treatment of partial and generalized epilepsy (2007) (38)
- Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy (2018) (38)
- BGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy (2014) (38)
- Cognitive functioning over 3 years in community dwelling older adults with chronic partial epilepsy (2007) (38)
- Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new‐onset epilepsy: A randomized double‐blind clinical trial (2010) (38)
- Predictive Value of MRI‐Identified Mesial Temporal Sclerosis for Surgical Outcome in Temporal Lobe Epilepsy: An Intent‐to‐Treat Analysis (2000) (37)
- Interictal epileptiform discharge effects on neuropsychological assessment and epilepsy surgical planning (2016) (36)
- Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey (2016) (36)
- Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee (2020) (36)
- Teddy bears: An observational finding in patients with non-epileptic events (2003) (35)
- Antiepileptic Drug Treatment After Temporal Lobe Epilepsy Surgery: A Randomized Study Comparing Carbamazepine and Polytherapy (1992) (35)
- Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: A US database analysis (2018) (34)
- Congenital porencephaly and hippocampal sclerosis (1997) (33)
- Is the intracellular pH different from normal in the epileptic focus of patients with temporal lobe epilepsy? (1996) (33)
- Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US (2019) (32)
- Statistically driven identification of focal metabolic abnormalities in temporal lobe epilepsy with corrections for tissue heterogeneity using 1H spectroscopic imaging (2000) (32)
- Eclampsia, hippocampal sclerosis, and temporal lobe epilepsy (2004) (32)
- In vivo hippocampal metabolic dysfunction in human temporal lobe epilepsy. (2002) (31)
- Pattern-reversal visual evoked potentials in photosensitive epilepsy. (1984) (31)
- Estimating Epilepsy Incidence and Prevalence in the US Pediatric Population Using Nationwide Health Insurance Claims Data (2016) (31)
- THE EPILEPSIES: SEIZURES, SYNDROMES AND MANAGEMENT (2007) (30)
- Lamotrigine: A six-month, placebo-controlled, safety and tolerance study (1995) (30)
- Hyperammonemia following intravenous valproate loading (2009) (29)
- Clinical Presentations and Phenomenology of Myoclonus (2003) (29)
- Efficacy of Topiramate as Adjunctive Therapy in Refractory Partial Seizures: United States Trial Experience (1997) (29)
- Bilateral hippocampal atrophy (2001) (28)
- Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy (2018) (28)
- Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy. (2019) (28)
- Health-related quality of life in senior adults with epilepsy: what we know from randomized clinical trials and suggestions for future research (2003) (27)
- Correlation of Scalp EEG and 1H‐MRS Metabolic Abnormalities in Temporal Lobe Epilepsy (2001) (27)
- Long-term tolerability of lamotrigine: data from a 6-year continuation study (2004) (26)
- Treatment of refractory primary generalized epilepsy. (2004) (25)
- Determining empirically based self-reported cognitive change: Development of reliable change indices and standardized regression-based change norms for the multiple abilities self-report questionnaire in an epilepsy sample (2006) (25)
- Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis. (1999) (25)
- Lateralization of Epileptic Foci by Magnetic Resonance Imaging in Temporal Lobe Epilepsy; Reliability and Diagnostic Criteria (1991) (24)
- Verbal Retention Lateralizes Patients with Unilateral Temporal Lobe Epilepsy and Bilateral Hippocampal Atrophy (2001) (23)
- CME Efficacy and tolerability of the new antiepileptic drugs I : Treatment of new onset epilepsy (2004) (23)
- The safety and tolerability of galantamine in patients with epilepsy and memory difficulties (2008) (22)
- Contribution of Neuropsychological Data to the Prediction of Temporal Lobe Epilepsy Surgery Outcome (1998) (22)
- Adherence to antiepileptic drugs among diverse older Americans on Part D Medicare (2017) (21)
- Temporal lobectomy in congenital porencephaly associated with hippocampal sclerosis. (2003) (20)
- Clinical Trials for Treatment of Primary Generalized Epilepsies (2003) (20)
- Occipitoparietal Epilepsy, Hippocampal Atrophy, and Congenital Developmental Abnormalities (2000) (20)
- Psychosocial outcome following temporal lobe surgery (1994) (20)
- Kaplan–Meier analysis on seizure outcome after epilepsy surgery: Do gender and race influence it? (2008) (20)
- Discordant Occurrence of Cerebral Unilateral Heterotopia and Epilepsy in Monozygotic Twins (1995) (19)
- Registry initiated to characterize vision loss associated with vigabatrin therapy (2011) (19)
- Amygdala atrophy and seizure outcome after temporal lobe epilepsy surgery (1998) (19)
- Tiagabine in clinical practice: effects on seizure control and behavior (2013) (18)
- Lamotrigine for startle-induced seizures (1999) (18)
- Chronic temporal lobe epilepsy: spatial extent and degree of metabolic dysfunction studied with magnetic resonance spectroscopy (MRS) (2004) (18)
- Newer antiepileptic drug use and other factors decreasing hospital encounters (2015) (18)
- Gender, Memory, and Hippocampal Volumes: Relationships in Temporal Lobe Epilepsy (2000) (17)
- A comparison of physicians’ attitudes and beliefs regarding driving for persons with epilepsy (2007) (17)
- Sabril® registry 5-year results: Characteristics of adult patients treated with vigabatrin (2016) (17)
- What does the U.S. Medicare administrative claims database tell us about initial antiepileptic drug treatment for older adults with new‐onset epilepsy? (2017) (17)
- Race/ethnicity: A predictor of temporal lobe epilepsy surgery outcome? (2005) (17)
- Brainstem auditory evoked responses in brainstem infarction. (1985) (17)
- Electroencephalographic Correlations of Extracranial and Epidural Electrodes in Temporal Lobe Epilepsy (1991) (16)
- Risk of pharmacokinetic interactions between antiepileptic and other drugs in older persons and factors associated with risk (2018) (16)
- Nonlinear Trends in Hippocampal Metabolic Function and Verbal Memory: Evidence of Cognitive Reserve in Temporal Lobe Epilepsy? (2000) (16)
- Oxcarbazepine in a monotherapy trial for partial seizures--placebo-controlled studies in neurology: where do they stop? (1999) (16)
- Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States (2011) (16)
- Late‐Onset Variant of Huntington's Chorea (1983) (15)
- Significance of fornix atrophy in temporal lobe epilepsy surgery outcome. (2003) (15)
- A double-blind, placebo-controlled study of remacemide hydrochloride in patients with refractory epilepsy following pre-surgical assessment (2002) (14)
- Antiepileptic drug trials: the view from the clinic (2012) (14)
- Bilateral hippocampal atrophy: Consequences to verbal memory following temporal lobectomy (2001) (14)
- Ezogabine: A New Angle on Potassium Gates (2011) (13)
- Temporal Relationship of EEG Abnormalities in Migraine to Headache and Medication (1981) (13)
- The Impact of Interictal Discharges on Performance (2018) (12)
- Diagnosis and management of low back pain. (1988) (12)
- Self-induced photosensitive absence seizures with ictal pleasure. (1986) (12)
- Geographic variation of epilepsy for older Americans: How close to the geographic variation of stroke? (2012) (11)
- Diagnostic Tests and Neurology Care for Medicare Beneficiaries With Seizures: Differences Across Racial Groups (2012) (11)
- Medical decision-making abilities in older adults with chronic partial epilepsy (2007) (11)
- Understanding the burden of focal epilepsy as a function of seizure frequency in the United States, Europe, and Brazil (2017) (10)
- Neurotoxicity following addition of intravenous valproate to lamotrigine therapy (2003) (10)
- Confirmatory factor analysis of the california verbal learning test in patients with epilepsy: relationship to clinical and neuropathological markers of temporal lobe epilepsy. (2004) (10)
- Global/local scoring modifications for the Rey-Osterrieth Complex Figure: Relation to unilateral temporal lobe epilepsy patients (2006) (10)
- Patterns of EEG frequency content during experimental transient ischaemia in subhuman primates. (1988) (10)
- Hippocampal 1 H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy (2007) (9)
- Which children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registry (2016) (9)
- Quality of Antiepileptic Treatment Among Older Medicare Beneficiaries With Epilepsy: A Retrospective Claims Data Analysis (2017) (9)
- Health care resource utilization before and after perampanel initiation among patients with epilepsy in the United States (2017) (8)
- Efficacy of lacosamide by focal seizure subtype (2014) (8)
- Seizure classification (1994) (8)
- Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy (2021) (6)
- Should thrombolysis be given to a stroke patient refusing therapy due to profound anosognosia? Author's reply (2005) (6)
- Clinical studies of topiramate. (1999) (6)
- Trigeminal stimulation (2013) (6)
- Epilepsy case studies. (2006) (6)
- Methaqualone withdrawal syndrome with photoparoxysmal responses and high‐ amplitude visual evoked potentials (1986) (6)
- Cerebral complications of angiography for transient ischemia and stroke (1980) (6)
- Cessation of gamma activity in the dorsomedial nucleus associated with loss of consciousness during focal seizures (2015) (5)
- Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain (2017) (5)
- Morbidity of epidural strip electrode implantation for epilepsy presurgical evaluation (1996) (5)
- High health care costs in minority groups of older US Medicare beneficiaries with epilepsy (2019) (5)
- New-onset lesional and nonlesional epilepsy in the US population: Patient characteristics and patterns of antiepileptic drug use (2019) (5)
- Epilepsy drugs: getting it right the first time (2007) (5)
- Surgical Treatment of Epilepsy: Initial Results Based Upon Epidural Electroencephalographic Recordings (1990) (5)
- American Epilepsy Society (AES): Written Comments to Norman E. “Ned” Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS) (2019) (4)
- Quality Indicator for Epilepsy Treatment 15 (QUIET-15): Intervening after recurrent seizures in the elderly (2017) (4)
- Superior Verbal Memory Outcome After Stereotactic Laser Amygdalohippocampotomy (2021) (4)
- Comparison of outcomes in patients with juvenile myoclonic epilepsy treated with lamotrigine, topiramate, zonisamide, or levetiracetam (2002) (3)
- Real‐world analysis of hospitalizations in patients with epilepsy and treated with perampanel (2021) (3)
- Be Sure to Read the Fine Print: The Agency for Healthcare Research and Quality Comparative Effectiveness Report on Antiepileptic Drugs (2012) (3)
- A steelworker with infrequent seizures (2003) (3)
- Collective Data Supports Efficacy of Multiple Subpial Transection (2002) (3)
- A 34-year-old man with recent onset of ataxia. (1986) (3)
- Placebo effect in antiepileptic drug trials (2003) (3)
- Management of epilepsy in older adults: A critical review by the ILAE Task Force on Epilepsy in the elderly (2022) (3)
- Group and individual level performance on the WMS-III auditory and visual memory subtests in patients with temporal lobe epilepsy (2000) (2)
- Quality-of-life results in adults with epilepsy using diazepam nasal spray for seizure clusters from a long-term, open-label safety study (2022) (2)
- Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis (1999) (2)
- Complications following angiography (1981) (2)
- Thirty-day readmission after status epilepticus in the United States: Insights from the nationwide readmission database (2020) (2)
- Neuropsychological profile associated with MRI-identified coexisting temporal lobe developmental malformations and hippocampal sclerosis (1999) (2)
- Oxcarbazepine (1999) (2)
- The Challenge of Treatment Selection for Epilepsy (2001) (2)
- Attack of the Pocket Monsters: No Lasting Effects (2004) (2)
- Robot Assisted MRI-Guided LITT of the Anterior, Lateral, and Medial Temporal Lobe for Temporal Lobe Epilepsy (2020) (2)
- Naming seizures. Commentary (2005) (1)
- Impact of Medicaid antiepileptic drug formulary restrictions on health outcomes and costs (P6.279) (2018) (1)
- PND53 UNCONTROLLED EPILEPSY IN A MEDICAID POPULATION (2011) (1)
- Step therapy is not appropriate for antiepileptic drugs. (2015) (1)
- 12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis (P11-1.003) (2023) (1)
- Should Monotherapy for Epilepsy Be Reconsidered (2009) (1)
- Pregabalin: The Next New Thing (2005) (1)
- PMD1 IMPACT OF VAGUS NERVE STIMULATION (VNS) THERAPY ON CLINICAL OUTCOMES AND COSTS IN MEDICAID PATIENTS WITH DRUG-RESISTANT EPILEPSY (2011) (1)
- Real-world impact of antiepileptic drug combinations with versus without perampanel on healthcare resource utilization in patients with epilepsy in the United States (2021) (1)
- Who Am I? Forgetting Your past is Forgetting Yourself (2016) (1)
- Implications of Seizure-Cluster Treatment on Healthcare Utilization: Use of Approved Rescue Medications (2022) (1)
- Balancing reality with hope in epilepsy therapy (2018) (1)
- Intracranial EEG electrodes (1990) (1)
- Complications following angiography (1981) (1)
- Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy (2022) (1)
- Reoperations for Epilepsy: How Many Times Should We Bat? (2020) (1)
- What does the future hold for patients with epilepsy? (2012) (1)
- Occult gliomas demonstrated by serial CT scans in new onset of seizures. (1988) (1)
- WAVEFORM AND DISTRIBUTION OF EPIDURAL EEG PATTERNS AT THE ONSET OF TEMPORAL LOBE SEIZURES (1988) (1)
- Measure for Measure: Measuring the Usefulness of Measuring Antiseizure Medication Levels (2020) (1)
- Defining a Place for Lacosamide in the Intensive Care Unit (2018) (1)
- Topiramate: a viewpoint by Edward Faught. (2003) (1)
- Efficacy and Tolerability of the New Antiepileptic Drugs , II : Treatment of Refractory Epilepsy : Report of the TTA and QSS (2004) (1)
- A neural network study using quantitative 1 H magnetic resonance spectroscopy (2000) (1)
- Phase IV Vision Study Evaluates Retinal Structure and Function in Adult Patients with Refractory Complex Partial Seizures Treated with Vigabatrin (P07.255) (2012) (1)
- The Triad of Left Hemiplegia, Hemihypesthesia, and Homonymous Hemianopsia: Implications for Rehabilitation (1994) (1)
- The Cost of the Second Seizure: Rethinking the Treatment Decision (2019) (0)
- The Sabril® Registry After 5 Years: Patient Characteristics and Vision Loss (P7.006) (2015) (0)
- EPILEPSY SURGERY IN THE FRONTAL LOBE: TERRA INCOGNITA OR NEW FRONTIER? (2007) (0)
- EEG in clinical practice (1997) (0)
- Reflections on monotherapy trials for epilepsy (2016) (0)
- PND24 IMPACT OF NON-ADHERENCE TO ANTIEPILEPTIC DRUGS ON MORBIDITY (2008) (0)
- ASSOCIATION OF APOLIPOPROTEIN E ALLELE 4 WITH LATE-ONSET FAMILIAL AND SPORADIC ALZHEIMER'S DISEASE (2011) (0)
- The pervasive influence of conflicts of interest: a personal perspective. (2010) (0)
- In response: Research using archival health care data: Let the buyer beware (2015) (0)
- Randomized controlled trial of zonisamide for the treatment of partial-onset seizures. Authors' reply (2002) (0)
- Author response: Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US (2020) (0)
- Wisconsin Card Sorting Performance in Patients With Temporal Lobe Epilepsy: Clinical and Neuroanatomical Correlates (2000) (0)
- Reply (1998) (0)
- Clinical Research Correlation of Scalp EEG and 1 H-MRS Metabolic Abnormalities in Temporal Lobe Epilepsy (2001) (0)
- Time to Switch or Add on of an AED in Newly Diagnosed Epilepsy Populations: A US Database Analysis (P6.350) (2016) (0)
- 1H-magnetic resonance spectroscopic imaging detected hippocampal metabolic abnormalities correlate with neuropsychological performance: Preliminary findings in mesial temporal lobe epilepsy patients (1999) (0)
- Tolerability of Lacosamide 200 mg/day Starting Dose: Post-hoc Analysis of Conversion to Lacosamide Monotherapy Study (P4.264) (2015) (0)
- Refl ection and Reaction (2007) (0)
- Open letter (and invitation) to the pharmaceutical industry: “No, we cannot just present your slide deck …” (2010) (0)
- Factor structure of the CVLT in epilepsy patients: relationship to hippocampal volume and seizure focus (2001) (0)
- Comparing Patient Characteristics and Treatment Patterns in Prevalent Patients with or without Lesional Epilepsy: A US Database Analysis (P1.087) (2016) (0)
- Absence Seizures in an Adult (2008) (0)
- A Unique Partnership for Research in Epilepsy Outcomes: The Emory University and UCB Pharma Collaboration (P5.064) (2014) (0)
- Current management of atherosclerotic stroke. (1987) (0)
- Four-Year Results from the Sabril® Registry Yield a Low Rate of Discontinuation Secondary to Reports of Visual Deficits (S39.007) (2014) (0)
- Epilepsy and nonadherence (2016) (0)
- Predicting a Storm by Watching the Waves (2018) (0)
- The epidemiology of epilepsy in older adults: A narrative review by the ILAE Task Force on Epilepsy in the Elderly (2023) (0)
- SB3 Incremental Clinical and Economic Burden of Uncontrolled Partial-Onset Seizures in a Privately-Insured Population (2012) (0)
- Research Demonstrating the Effects of Interictal Epileptiform Discharges on Cognition and Behavior (0)
- Epilepsia Reviewers (2004) (0)
- The relationship between presurgical neuropsychological variables and postsurgical quality of life outcome in temporal and extratemporal epilepsy patients (1998) (0)
- Economic aspects of treating seizure clusters (2022) (0)
- SURGICAL TREATMENT OF HYPOTHALAMIC HAMARTOMA. AUTHORS' REPLY (1998) (0)
- Epilepsy Foundation of America Concerns Index (2013) (0)
- Arteriographic findings and neurologic symptoms (1981) (0)
- 30-Day Re-admission After Status Epilepticus in Unites States: Insights From Nationwide Re-admission Database (2019) (0)
- An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States. (2023) (0)
- Indications for angiography in stroke (1984) (0)
- Comparing the healthcare utilization and direct medical costs in newly diagnosed epilepsy patients and a comparator non-epilepsy population: a US database analysis (S34.002) (2017) (0)
- Epilepsy After Sixty (2014) (0)
- Seizures and Epilepsy, Second Edition (Book) (2014) (0)
- Encephalopathy in a 68-year-old man. (1987) (0)
- Safety and tolerability of lacosamide monotherapy in elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain (P1.239) (2015) (0)
- Occipitoparietal Epilepsy, Hippocampal Atrophy, and Congenital Developmental Abnormalities (2000) (0)
- Predicting individuals at risk for memory decline following anterior temporal lobectomy (1997) (0)
- Restoring EEG to its Rightful Place in Alzheimer Disease Care (2021) (0)
- Determining Reliable Cognitive Change Following Epilepsy Surgery: Development of Reliable Change Indices and Standardized Regression‐Based Change Norms for the WMS‐3 and WAIS‐3 (2006) (0)
- Real Spikes Crash Virtual Cars (2016) (0)
- The Winner by a Nose: Intranasal Midazolam (2019) (0)
- Focal Ablations of the Amygdala and Hippocampus Infrequently Results in Verbal Memory Impairment (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Edward Faught?
Edward Faught is affiliated with the following schools:
